Global Cell-based Assay Market Expected to Reach $10,617 Million by 2023 - Allied Market Research

PORTLAND, Oregon and PUNE, India, November 20, 2017 /PRNewswire/ --

According to a new report published by Allied Market Research, titled, "Cell-based Assay Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023 [https://www.alliedmarketresearch.com/cell-based-assay-market ]," the global cell-based assay market was valued at $3,625 million in 2016, and is projected to reach $10,618 million by 2023, growing at a CAGR of 16.5% from 2017 to 2023. The consumables product segment accounted for nearly three-fifths share of the market in 2016.

(Logo: http://photos.prnewswire.com/prnh/20140911/647229 )

Cell-based assays are procedures that are widely used in drug discovery and high-throughput screening of compounds due to the advantages of predictability, possibility of automation, multiplexing, and miniaturization. They are highly beneficial for use in early stages of the drug discovery processes.

Do Enquiry for Sample Report@ https://www.alliedmarketresearch.com/request-sample/4425

The major factors that drive the global cell-based assay market are rise in technological advancements in cell-based assays, growth in availability of funds & investment for research, and increase in drug discovery programs globally. In addition, adoption of high-throughput screening for drug discovery enhances the demand for cell-based assay, thereby providing lucrative opportunities for market growth. However, accuracy & standardization concerns and costs associated with cell-based assays restrain the market growth.

The consumables product segment occupies the highest share, owing to their sheer usage and need throughout the pre-requisite steps of cell-based assay methodologies. The drug discovery application segment is anticipated to dominate the global cell-based assay market, and it accounted for over one-third of the total share in 2016.

Do Enquiry before purchasing Report@ https://www.alliedmarketresearch.com/purchase-enquiry/4425

At present, the pharmaceutical companies segment dominates the end-user segment and is expected to grow at a CAGR of 14.6% from 2017 to 2023. Cell-based assay possesses the potential to recognize a broad spectrum of compounds and supplement the generation of potent biomarkers in medicine.

Key Findings of the Cell-based Assay Market:

        
        - The services product segment is anticipated to grow at the highest CAGR from 2017
          to 2023.
        - The predictive toxicology application segment is expected to witness the highest
          growth rate.
        - The pharmaceutical companies segment generated the highest revenue in 2016, and is
          expected to continue its dominance in the future as well.
        - North America dominated the global cell-based assay market, and is projected to grow
          at a CAGR of 16.2%.

The major companies profiled in the report include Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Lonza Group Ltd., Cell Signaling Technology, Inc., and Promega Corporation. The other players in the value chain include (profiles not included in the report) include Macrogen, Inc., New England Biolabs, Inc., Cisbio Bioassays, Cell Biolabs, Inc., and DiscoverX Corporation.

Ask for discount before buying@ https://www.alliedmarketresearch.com/get-discount/4425

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

        

        Contact: 
        Dhananjay Potle 
        5933 NE Win Sivers Drive 
        #205, Portland, OR 97220 
        United States 
        Toll Free: +1-800-792-5285 
        UK: + 44-845-528-1300 
        Hong Kong: + 852-301-84916 
        India (Pune): +91 20 66346060 
        Fax: +1   855   550-5975 
        help@alliedmarketresearch.com 

Web: https://www.alliedmarketresearch.com

    Photo: 
    http://photos.prnewswire.com/prnh/20140911/647229

SOURCE Allied Market Research